PCN57 TRASTUZUMAB USE FOR METASTATIC BREAST CANCER–IS “MEDIAN TIME TO TREATMENT FAILURE” AN ACCURATE PARAMETER FOR BUDGET IMPACT ANALYSIS?

Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63487-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63487-0/fulltext
Section Title :
Section Order : 339
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63487-0&doi=10.1016/S1098-3015(10)63487-0
HEOR Topics :
Tags :
Regions :